ABT: Abbott Laboratories Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ABT: Abbott Laboratories

ABT 125.52

-0.9%

12:23 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: HerbVic	1/15/2004 7:51:04 AM
	Read Replies (1) of 33

Abbott Labs to acquire maker of blood-monitoring equipment January 14, 2004 North Chicago, Ill. (Associated Press) -- Abbott Laboratories Inc. has agreed to buy blood-monitoring equipment maker TheraSense Inc. for $1.2 billion in cash in a deal that would broaden Abbott's involvement in products used in the treatment of diabetes. The transaction announced Tuesday is expected to be completed during the second quarter, pending approval by regulators and shareholders. TheraSense, based in Alameda, Calif., has developed, manufactured and marketed blood glucose self-monitoring systems since June 2000. Abbott has been in the blood glucose monitoring field since its acquisition of MediSense in 1996. indystar.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next